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Abstract
Background
Systematic reviews of randomised controlled trials (RCTs) have suggested that maternal
vitamin D (25[OH]D) and calcium supplementation increase birth weight. However, limita-
tions of many trials were highlighted in the reviews. Our aim was to combine genetic and
RCT data to estimate causal effects of these two maternal traits on offspring birth weight.
Methods and findings
We performed two-sample mendelian randomisation (MR) using genetic instrumental vari-
ables associated with 25(OH)D and calcium that had been identified in genome-wide asso-
ciation studies (GWAS; sample 1; N = 122,123 for 25[OH]D and N = 61,275 for calcium).
Associations between these maternal genetic variants and offspring birth weight were calcu-
lated in the UK Biobank (UKB) (sample 2; N = 190,406). We used data on mother–child
pairs from two United Kingdom birth cohorts (combined N = 5,223) in sensitivity analyses
to check whether results were influenced by fetal genotype, which is correlated with the
maternal genotype (r� 0.5). Further sensitivity analyses to test the reliability of the results
included MR-Egger, weighted-median estimator, ‘leave-one-out’, and multivariable MR
analyses. We triangulated MR results with those from RCTs, in which we used randomisa-
tion to supplementation with vitamin D (24 RCTs, combined N = 5,276) and calcium (6
RCTs, combined N = 543) as an instrumental variable to determine the effects of 25(OH)D
and calcium on birth weight. In the main MR analysis, there was no strong evidence of an
effect of maternal 25(OH)D on birth weight (difference in mean birth weight −0.03 g [95% CI
−2.48 to 2.42 g, p = 0.981] per 10% higher maternal 25[OH]D). The effect estimate was con-
sistent across our MR sensitivity analyses. Instrumental variable analyses applied to RCTs
suggested a weak positive causal effect (5.94 g [95% CI 2.15–9.73, p = 0.002] per 10%
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Data Availability Statement: Our study uses two-
sample mendelian randomisation (MR) and
instrumental variable analyses applied to RCTs. We
used both published summary results (i.e., taking
results from published research papers and
websites) and individual participant cohort data as
follows: Journal-published and website summary
data were used for one of the two sample MR
(published GWAS of circulating 25[OH]D, calcium,
height, and education) and also for the application
of instrumental variable analyses to RCTs of
higher maternal 25[OH]D), but this result may be exaggerated because of risk of bias in the
included RCTs. The main MR analysis for maternal calcium also suggested no strong evi-
dence of an effect on birth weight (−20 g [95% CI −44 to 5 g, p = 0.116] per 1 SD higher
maternal calcium level). Some sensitivity analyses suggested that the genetic instrument for
calcium was associated with birth weight via exposures that are independent of calcium lev-
els (horizontal pleiotropy). Application of instrumental variable analyses to RCTs suggested
that calcium has a substantial effect on birth weight (178 g [95% CI 121–236 g, p = 1.43 ×
10−9] per 1 SD higher maternal calcium level) that was not consistent with any of the MR
results. However, the RCT instrumental variable estimate may have been exaggerated
because of risk of bias in the included RCTs. Other study limitations include the low
response rate of UK Biobank, which may bias MR estimates, and the lack of suitable data to
test whether the effects of genetic instruments on maternal calcium levels during pregnancy
were the same as those outside of pregnancy.
Conclusions
Our results suggest that maternal circulating 25(OH)D does not influence birth weight in oth-
erwise healthy newborns. However, the effect of maternal circulating calcium on birth weight
is unclear and requires further exploration with more research including RCT and/or MR
analyses with more valid instruments.
Author summary
Why was this study done?
• Birth weight that is lower or higher than average has been associated with poor health
outcomes across the life span, including infant mortality, cardiovascular disease, and
type 2 diabetes.
• If we can identify modifiable maternal factors in pregnancy that are causally related to
birth weight, we may be able to reduce the number of babies that are born with lower or
higher than optimal birth weight. This may in turn help to reduce the associated poor
health outcomes.
• Previous studies have suggested that higher maternal 25(OH)D and calcium in preg-
nancy are associated with higher birth weight. However, many of those studies used
conventional multivariable regression in observational studies and may be subject to
residual confounding. Few of them estimated the size of the effect of either maternal
25(OH)D or calcium levels on birth weight.
What did the researchers do and find?
• We estimated the effects of maternal gestational 25(OH)D and calcium levels on off-
spring birth weight using mendelian randomisation, a method that uses genetic data to
overcome certain limitations of traditional observational studies—for example, residual
confounding.
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vitamin D and calcium supplementation. The
references to those published data sources are
provided in the main paper. We used individual
participant data for the second MR sample and for
undertaking sensitivity analyse from the UK
Biobank, ALSPAC, and EFSOCH cohorts. The data
in UK Biobank and ALSPAC are fully available, via
managed systems, to any researchers. The
managed system for both studies is a requirement
of the study funders, but access is not restricted on
the basis of overlap with other applications to use
the data or on the basis of peer review of the
proposed science. UK Biobank: Full information on
how to access these data can be found here -
https://www.ukbiobank.ac.uk/using-the-resource/.
ALSPAC: The ALSPAC data management plan
(http://www.bristol.ac.uk/alspac/researchers/data-
access/documents/alspac-data-management-plan.
pdf) describes in detail the policy regarding data
sharing, which is through a system of managed
open access. The following steps highlight how to
apply for access to the data included in this paper
and all other ALSPAC data. (1) Please read the
ALSPAC access policy (PDF, 627 kB), which
describes the process of accessing the data and
samples in detail and outlines the costs associated
with doing so. (2) You may also find it useful to
browse the fully searchable ALSPAC research
proposals database, which lists all research
projects that have been approved since April 2011.
(3) Please submit your research proposal for
consideration by the ALSPAC Executive
Committee. You will receive a response within 10
working days to advise you whether your proposal
has been approved. If you have any questions
about accessing data, please email alspac-
data@bristol.ac.uk. EFSOCH: Requests for access
to the original EFSOCH dataset should be made in
writing in the first instance to the EFSOCH data
team via the Exeter Clinical Research Facility
(crf@exeter.ac.uk).
Funding: This study was supported by the US
National Institute of Health (R01 DK10324), the
European Research Council under the European
Union’s Seventh Framework Programme (FP7/
2007-2013)/ERC grant agreement no 669545, and
the NIHR Biomedical Centre at the University
Hospitals Bristol NHS Foundation Trust and the
University of Bristol. Core funding for ALSPAC is
provided by the UK Medical Research Council and
Wellcome (Grant ref: 102215/2/13/2) and the
University of Bristol. Genotyping of the ALSPAC
maternal samples was funded by the Wellcome
Trust (WT088806), and the offspring samples were
genotyped by Sample Logistics and Genotyping
Facilities at the Wellcome Trust Sanger Institute
and LabCorp (Laboratory Corportation of America)
• We analysed genetic data on 190,406 women from the UK Biobank who reported the
birth weight of their first child, along with the results from published studies of genetic
associations with 25(OH)D and calcium levels in 122,123 and 61,275 individuals,
respectively.
• We checked that the results were not biased by offspring genotype using data from two
UK birth cohorts, the Avon Longitudinal Study of Parents and Children (ALSPAC; n =
4,576 mother–child pairs) and Exeter Family Study of Childhood Health (EFSOCH; n =
647 mother–child pairs), respectively.
• To strengthen our causal understanding, we triangulated the mendelian randomisation
results with findings from randomised controlled trials in which we used randomised
status (to vitamin D or calcium supplementation) as an instrumental variable to esti-
mate the effect of 25(OH)D or calcium on birth weight.
• We found no evidence of a strong effect of maternal 25(OH)D on birth weight.
• We found inconsistent evidence of effects of maternal calcium on birth weight.
What do these findings mean?
• Our findings do not support using vitamin D supplementation during pregnancy or
preconceptually to influence offspring birth weight.
• The effect of calcium on birth weight is still unclear and needs further investigation in
well-powered genetic studies and/or well-conducted randomised controlled trials.
Introduction
Infants with lower or higher birth weight (BW) than average are at an increased risk of neona-
tal mortality and morbidity [1]. BW is also inversely associated with some adverse adult health
outcomes, including coronary heart disease [2], type 2 diabetes [3], poor cognitive ability [4],
and several types of cancer [5], with most of these associations being linear across most of the
BW distribution. BW is an indicator of conditions in utero and may be influenced by modifi-
able factors in the maternal circulation. For example, there is evidence that higher maternal
fasting glucose is causally related to greater fetal growth and higher BW [6,7], which increases
the risk of complications during delivery. However, relatively little is known about the causal
influences of other maternal factors. More evidence is required on how modifying the in utero
environment might influence BW and associated health outcomes.
Maternal gestational circulating 25(OH)D [8] and calcium [9] may be modifiable risk fac-
tors that impact fetal growth and hence BW. Several observational studies using conventional
multivariable regression analyses suggest positive associations of maternal 25(OH)D and cal-
cium with infant BW [10–13]; however, these results might be explained by residual confound-
ing. Systematic reviews of randomised controlled trials (RCTs) of gestational supplementation
with vitamin D [14] or calcium [15] have suggested that this supplementation increases BW.
However, the authors of the latest vitamin D supplementation systematic review concluded
that most of the trials were small and of low quality, and the difference in mean BW was small
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and unlikely to be of clinical or public health importance [16]. For the calcium supplementa-
tion systematic review, the authors noted that for most of the trials, there was a low risk of bias
based on a score that did not include intention to treat as one of the risk-of-bias criteria. How-
ever, there were high levels of heterogeneity in the results between the trials, bringing into
question the clinical importance of calcium supplementation on BW [15].
Mendelian randomisation (MR) is a method in which genetic variants associated with a
modifiable exposure are used as instrumental variables to estimate the causal effect of the expo-
sure on an outcome [17]. As genetic variants are fixed at conception and are generally not
associated with classical confounders, MR is less susceptible to bias resulting from reverse cau-
sation and residual confounding [17]. We have previously performed an MR study on the
effects of maternal adiposity related exposures on BW, finding a positive effect of body mass
index (BMI) and blood glucose and an inverse causal effect of systolic blood pressure on BW
[6]. In that study, there was evidence of a possible positive causal effect of 25(OH)D on BW;
however, the CIs were wide and included the null value [6]. A possible causal association of
maternal circulating calcium with infant BW was not explored in that study, and to the best of
our knowledge, there have been no MR studies of that association. The aim of this study was to
use MR to explore whether there are causal effects of maternal circulating 25(OH)D and cal-
cium on BW and, if so, what the magnitude those effects are. With the release of new UK Bio-
bank (UKB) data [18], we have a substantially increased sample size in comparison to the
earlier MR study of 25(OH)D, as well as access to more genetic instruments for 25(OH)D [19],
both of which will increase statistical power and hence effect estimate precision. We comple-
ment our MR analyses by triangulating results with findings from instrumental variable analy-
ses applied to RCTs of supplementation with vitamin D or calcium [20].
Methods
The analyses plan was developed by RMF, DAL, WDT, and MCB, prior to any analyses begin-
ning. It was acted on by WDT and MCB. The analysis plan has not been published but was
informally recorded in meeting notes. We made one change to the overall study plans after
completing analyses; we undertook risk-of-bias assessment of the RCTs with a focus on factors
that might mean instrumental variable assumptions were violated. This was motivated by dif-
ferences in results comparing MR to instrumental variables in RCTs, particularly in relation to
the effects of calcium on BW. We made one change to the plan following reviewers’ comments;
we undertook two multivariable MR analyses to adjust for potential confounders. These were
(1) multivariable MR of the association of 25(OH)D with BW adjusting (genetically) for
maternal height and (2) partial multivariable MR of the association of calcium with BW adjust-
ing (genetically) for maternal educational level.
The study design and different data sources are summarised in Fig 1, with Table 1, S1, S2,
S3 and S4 Text, S1, S2, S3 and S4 Tables, S1, S2 and S3 Figs providing more data on each study
that has contributed to this paper. Details of participant consent are described in S1 Text. Ethi-
cal approval for data extraction from all of the cohorts used in this study was granted from the
appropriate authorities (for more details, see S1 Text). This study is reported according to the
Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) guideline
(S1 Checklist).
Mendelian randomisation
We used two-sample summary data MR to explore the effect of maternal circulating vitamin D
(25[OH]D) and calcium levels on offspring BW [23]. We used (1) summary data from pub-
lished genome-wide association (GWA) studies (GWAS) for the associations of genetic
Association of maternal circulating 25(OH)D and calcium on birth weight
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variants (single-nucleotide polymorphisms [SNPs]) with 25(OH)D [19,24] or calcium [25]
(sample 1) and (2) summary data for the associations of SNPs with BW from UKB [18] (sam-
ple 2). Summary data from two UK birth cohorts, the Avon Longitudinal Study of Parents and
Children (ALSPAC) [26] and Exeter Family Study of Childhood Health (EFSOCH) [27], were
generated for use in sensitivity analyses to explore bias due to fetal genotype. In all studies, we
excluded participants of non–white European origin (S2 Text describes how ethnicity was
defined in each study). Following these exclusions, we included 190,406 women from UKB
who had valid data on BW of first child and GWAS data, 4,576 mother–offspring pairs from
ALSPAC, and 647 mother–offspring pairs from EFSOCH who all had offspring BW and
maternal and offspring GWAS data.
BW and serum 25(OH)D measurement
The UKB is a study of 502,655 participants [28]. Female participants (N = 273,495) were also
asked to report the BW of their first child. Female participants that reported having a multiple
first birth were excluded from our analyses (N = 1,364). A total of 216,839 women with a sin-
gleton pregnancy for their first child reported the BW of their first child. Values were reported
to the nearest whole pounds and were converted to kilograms by multiplying by 0.454 for our
analyses. When women reported the BW of the first child at multiple time points (N = 11,353),
we used the mean of all measures after excluding any women with a difference of>1 kg
between any two measures (N = 31). We further excluded from the whole sample any women
who reported the BW of their first child < 2.2 kg or > 4.6 kg (N = 6,333). This was done to
reduce bias from reporting errors and, in relation to those < 2.2 kg, to exclude extreme pre-
term births, given that we do not have information on gestational age. BW of first child was
Fig 1. Summary of methods and data contributing to this study. ALSPAC, Avon Longitudinal Study of Parents and Children; EFSOCH, Exeter
Family Study of Childhood Health; IVW, inverse variance–weighted; MR, mendelian randomisation; RCT, randomised controlled trial; SNP, single-
nucleotide polymorphism.
https://doi.org/10.1371/journal.pmed.1002828.g001
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Table 1. Characteristics of the studies used to obtain 25(OH)D/calcium SNPs’ (genetic instrumental variables)
effects on offspring birth weight.
Study Average/Typical Value of Study
Country UK Biobank United Kingdom
ALSPAC United Kingdom
EFSOCH United Kingdom
Offspring years of birth UK Biobank 1954–2011
ALSPAC 1991–1993
EFSOCH 2000–2004
Number of participants UK Biobank 190,406
ALSPAC 4,576
EFSOCH 647
Maternal age, years UK Biobank 25.9 (5.0)
ALSPAC 29.0 (4.6)
EFSOCH 30.4 (5.2)
Maternal BMI, kg/m2 UK Biobank 27.07 (5.03)
ALSPAC 22.91 (3.72)
EFSOCH 24.03 (4.32)
Maternal height, cm UK Biobank 162.5 (6.1)
ALSPAC 164.5 (6.7)
EFSOCH 165.0 (6.3)
Birth weight, g UK Biobank 3,227 (476)
ALSPAC 3,495 (471)
EFSOCH 3,514 (475)
Gestational age, weeks UK Biobank NA
ALSPAC 39.8 (1.3)
EFSOCH 40.1 (1.2)
Offspring sex, % male UK Biobank NA
ALSPAC 49
EFSOCH 52
Maternal systolic blood pressure, mmHg UK Biobank 141 (24)
ALSPAC 133 (13)
EFSOCH NA
Mothers smoking, %a UK Biobank 12
ALSPAC 15
EFSOCH 14
Townsend deprivation indexb UK Biobank −1.66 (2.86)
ALSPAC NA
EFSOCH 0.23 (3.29)
Educational attainment: mothers with a university degree, % UK Biobank 47
ALSPAC 14
EFSOCH NA
Western dietc (SD) UK Biobank −0.087 (0.98)
ALSPAC NA
EFSOCH NA
(Continued)
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regressed against the women’s reported age at first birth and UKB assessment centre location
to reduce heterogeneity in reporting bias by these characteristics. Residuals from that regres-
sion model were then standardised to a mean of 0 and an SD of 1, with the standardised resid-
uals being used in all analyses and final results converted back to grams. The analyses were
done on standardised residuals to reduce the amount of computing power needed when doing
the initial GWA analyses, and so the summary GWAS data that we used for our main analyses
were already in this standardised format. UKB participants’ (women and men) reports of their
own BWs were used in sensitivity analyses described below, and similar methods of exclusion
and use of standardised (on age at assessment and centre) residuals, with conversion of results
back to grams, were used for own BW (see S3 Text for further details).
In ALSPAC and EFSOCH, BW was extracted (in grams) from obstetric clinical records at
the time of birth, which occurred between 1991 and 1992 (mean [SD] age of mothers 29 [4.6]
years) in ALSPAC [26] and between 2000 and 2004 (mean age of mothers 30.4 [5.2] years) in
EFSOCH [27].
The GWAS of 25(OH)D and calcium that we have used in our MR analyses were under-
taken on adult European-origin (nonpregnant) women and men. Our MR analyses assume
that the magnitude of gene instrument variable-25(OH)D (or calcium) association from those
studies are the same in women during pregnancy. We were able to test this for 25(OH)D in
ALSPAC, in which 25(OH)D was measured during pregnancy in mothers, using methods that
have previously been reported [29] (see S4 Text). Neither 25(OH)D nor calcium were mea-
sured during pregnancy in UKB or EFSOCH; calcium was not measured in ALSPAC.
Genotyping
For UKB, we analysed data from the May 2017 release of imputed genetic data, which have
been extensively described elsewhere [30]. Given the reported technical error with non-HRC
imputed variants [31], we focused exclusively on the set of approximately 40 million imputed
variants from the HRC reference panel.
Table 1. (Continued)
Study Average/Typical Value of Study
Age of assessment for age of first birth, years UK Biobank 58.0 (7.8)
ALSPAC NA
EFSOCH NA
aIn ALSPAC and EFSOCH, this is the percentage of women who smoked during pregnancy; for UK Biobank, it is the
percentage of women who smoke.
bAn area deprivation index that takes summary data on deprivation measures from the census for a defined small
geographical area (percentage of households without a motor vehicle, percentage of households with more than one
person per room, percentage of households not owner-occupied, and percentage of residents who are unemployed),
converts them to SD scores across all areas of the UK, and then sums them to give a relative area deprivation value,
such that a higher score indicates greater deprivation for the area compared to the UK as a whole [21]; in UK
Biobank, these reflect adult area of residence deprivation based on the postcode provided by the participants at their
baseline assessment (aged 40–60 years).
cWestern diet is a principal component of variation in reported diet in UK Biobank. Variation in diet was measured
using a dietary questionnaire [22].
Abbreviations: ALSPAC, Avon Longitudinal Study of Parents and Children; BMI, body mass index; EFSOCH, Exeter
Family Study of Childhood Health.
https://doi.org/10.1371/journal.pmed.1002828.t001
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To account for population structure and relatedness, a linear mixed model implemented in
BOLT-LMM v2.3 [32] was used to perform genome-wide association (GWA) analysis of BW
in the UKB sample. Only autosomal SNPs that were common (MAF > 1%), in Hardy Wein-
berg equilibrium (HWE; p-value > 1 × 10−6), passed QC in all 106 batches, and were present
on both genotyping arrays were included in the genetic relationship matrix (GRM). For the
GWA analyses of BW of the first child (i.e., using the maternal genotype), the genotyping
array and genotyping release (interim versus full) were included as covariates in the regression
model. For the GWAS of participants’ own BW (see below under ‘Exploring violation of MR
assumptions’ for the rationale behind these analyses), genotyping array, age at baseline, and
sex were adjusted for in all models.
In both ALSPAC and EFSOCH, the SNPs used in this study (see below) were taken from
genome-wide imputed data that had been completed for both the mothers and their offspring
(fetal genotype). In ALSPAC, maternal data were obtained from the Illumina 610 Quad Array,
and fetal data were obtained from the Illumina 550 Quad Array. In EFSOCH, maternal and
fetal data were obtained from the Illumina Infinium HumanCoreExome-24. For both
ALSPAC and EFSOCH, genotype data were imputed against Haplotype Reference Consortium
HRC v1.1 reference panel after quality control (MAF > 1%, HWE > 1 × 10−6, sex mismatch,
kinship errors, and 4.56 SD from the cluster mean of any subpopulations cluster) [26,33].
SNP selection and summary data for SNP–25(OH)D and SNP–calcium
associations
We searched for the largest well-conducted GWAS to identify genetic variants (SNPs) that
could be used as instrumental variables for circulating 25(OH)D and calcium and to obtain
summary data of genetic instrumental variable (SNP) associations with 25(OH)D and calcium
for use in our two-sample MR.
For 25(OH)D, we used summary association results for SNPs identified in two GWAS
[19,24], with the largest of these including 79,366 participants from 31 studies in discovery
analyses and 42,757 participants from two studies in replication analyses. In our main analyses,
we used seven SNPs, which were not in linkage disequilibrium, from either of the GWAS that
had a p-value of 5 × 10−8 in discovery analyses and were replicated. Two of the SNPs discov-
ered in the largest GWAS (rs3755967 and rs17216707) were different from, but in the same
loci as, two SNPs identified in an earlier, more commonly used GWAS (rs2282679 and
rs6013897, respectively) [34] that have been commonly used as instruments of 25(OH)D in
previous MR analyses. We measured linkage disequilibrium between these SNPs in white
Europeans (CEU) using LDLink [35,36] and found that both were>0.5, suggesting the SNPs
in each pair are tagging the same variant. In additional analyses, we separately conducted two
analyses with genetic instruments hypothesised to be involved in 25(OH)D synthesis (three
SNPs) and 25(OH)D metabolism (two SNPs) [37].
For calcium, we used summary association results for SNPs identified in a GWAS of 39,400
participants [25] from 19 studies in discovery analyses and 21,875 participants from 11 studies
as replication. We used seven SNPs, which were not in linkage disequilibrium, that were asso-
ciated with calcium levels at a p-value of 5 × 10−8 in discovery analysis and were replicated.
Further details of the 25(OH)D and calcium GWAS are provided in S1 Table, and a list of
the SNPs used in our MR analyses, together with their allele frequencies and per-allele associa-
tions, for 25(OH)D and calcium are provided in S2 Table.
For UKB, the summary results of associations between SNPs and first-child BW (maternal
genotype) or own BW (own genotype) were extracted from the GWAS results (see above for
details on how each GWAS was conducted). For ALSPAC and EFSOCH, individual-level SNP
Association of maternal circulating 25(OH)D and calcium on birth weight
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data were extracted and summary data were generated using multivariate linear regression of
the SNPs against BW (adjusting for gestational age and the child’s sex).
To make sure that the outcome data (BW) and exposure data (25[OH]D and calcium) were
comparable, the SNPs’ effects were harmonised to the 25(OH)D/calcium-raising alleles using
procedures that have previously been described [38].
Statistical analysis
The main and sensitivity two-sample MR methods are summarised in Table 2. In all analyses,
we estimated the effect of a 10% increase in 25(OH)D on BW in grams and the effect of 1 SD
increase in calcium on BW in grams, these units reflecting the units of 25(OH)D and calcium
used in the published GWAS. The value of a 10% increase in 25(OH)D will vary depending on
the ‘starting point’. In the gestational measures of 25(OH)D in ALSPAC, the median level of
25(OH)D is 61.8 nmol/l, the 25th percentile is 46.1 nmol/l, and the 75th percentile is 81.6
nmol/l; this makes a 10% increase from these points equivalent to 6.2 nmol/l, 4.6 nmol/l, and
8.2 nmol/l, respectively. The accepted range of calcium in a healthy population is between 8.5
mg/dl and 10.5 mg/dl [39], and dividing that range by four, we estimated that the SD of cal-
cium is 0.5 mg/dl (approximately 0.3 mmol/l).
The main effects were calculated in all three studies (UKB, ALSPAC, and EFSOCH) using
two methods: fixed-effect meta-analysis of Wald ratios [40] of the seven SNPs for 25(OH)D or
the seven SNPs for calcium and the inverse variance–weighted (IVW) instrumental variable
method [41] (Table 2).
Wald ratios were calculated by dividing each SNP’s effect on BW by the same SNP’s effect
on the exposure (25[OH]D or calcium). Standard errors were calculated by dividing the stan-
dard error of the SNP’s effect on BW by each SNP’s effect on the exposure. The ratios for each
SNP were then pooled using fixed-effect meta-analysis. I2 and leave-one-out analysis were
used to explore between SNP heterogeneity in their MR results (which, if present, may be due
to one or more of the SNPs being an invalid instrumental variable) [43].
For the IVW analysis, linear regression of the weighted (by inverse of their variance) SNPs’
associations with BW against the SNPs’ association with maternal circulating 25(OH)D or
Table 2. Summary of the four methods used for MR analysis.
Name of
Method
Wald Ratio (Meta-analysis) [40] Inverse Variance–Weighted [41] MR-Egger [41] Weighted Median [42]
Assumption There is no unbalanced horizontal
pleiotropy.
There is no unbalanced horizontal
pleiotropy.
That the effect of the genetic
instrument is not correlated
with any pleiotropic effect of
the instrument on the
outcome.
Less than 50% of the weight in the
analyses comes from invalid
instruments.
Equation Wald Ratio ¼ byjz
bxjz bIVW¼
PJ
j¼1
E2j se
  2
j bj
PJ
j¼1
E2j se
  2
j
bMR ¼
rj  b0
Ej
rj ¼ 100ðSj  
wj
2
Þ
Notes on
equation
βy|z is the SNP’s effect on the outcome,
and βx|z is the SNP’s effect on the
exposure. Wald ratios for each SNP
were pooled using fixed-effect meta-
analysis with inverse-variance weights.
βj is the ratio method estimate for each
genetic instrument, σej−2 is the
standard error of the genetic variants
effect on outcome, and Ej2 is the
genetic instruments effect on the
exposure.
β0 is the intercept, Ej is the
genetic instruments effect on
the exposure, and ρj is the
genetic instruments effect on
the outcome.
Multiple ratio estimates, or βj, are
calculated, and the median percentile
value is chosen. Each percentile value
is weighted. Sj is the sum of the
weights up to the given genetic
instrument, ρj is the percentile value,
and wj is the weight given to the
genetic instrument.
Abbreviations: MR, mendelian randomisation; SNP, single-nucleotide polymorphism.
https://doi.org/10.1371/journal.pmed.1002828.t002
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calcium was performed [41]. In IVW regression analyses, the intercept is forced through zero,
making the regression coefficient comparable to the pooled Wald ratio effect estimate. In the
presence of heterogeneity, standard errors are larger for IVW compared to pooled Wald ratios.
For our analysis, we estimated standard errors using a fixed-effects model and CIs using a t-
distribution.
Exploring possible violations of MR assumptions
Both the Wald ratio method and IVW instrumental variable analysis assume that (1) the SNPs
being used are robustly associated with maternal circulating 25(OH)D and calcium, (2) the
SNPs are not related to confounders of the associations of 25(OH)D and/or calcium with BW,
and (3) the SNPs have no effect on BW other than through 25(OH)D and calcium (also known
as the exclusion restriction criterion). In MR studies, horizontal pleiotropy is a common cause
of violation of this assumption. This would occur if our genetic instrument for 25(OH)D or
calcium influenced other factors, separately to 25(OH)D or calcium, and these other factors
influence BW independently of 25(OH)D or calcium. If this were the case, then the estimate
of effect that we assumed was due to, e.g., 25(OH)D would be the sum of a 25(OH)D effect
and the effect on the outcome of any other (pleiotropic) effects. The Wald ratio and IVW
approaches complement each other, with determining Wald ratios for each SNP providing an
opportunity to explore between SNP heterogeneity and IVW being closely related and compa-
rable to one of our sensitivity analyses (MR-Egger) used to test possible horizontal pleiotropy
(Table 2).
One possible source of bias is via the fetal genotype [44]. Maternal genetic variants that
influence 25(OH)D and calcium will be associated with the distributions of the same genetic
variants in the fetus (as mothers may transmit these alleles to their offspring), and if any of
these genetic variants affect fetal growth independently of an effect of maternal circulating
25(OH)D/calcium (for example, if fetal 25[OH]D or calcium influence fetal growth), there
will be an association between maternal SNPs and offspring BW that is not via the mother’s
gestational 25(OH)D or calcium. We tested this possible source of bias in two ways. First, we
adjusted the maternal SNP with offspring BW association for fetal genotype in a total of
5,223 genotyped mother–child pairs from the ALSPAC and EFSOCH studies. The Wald
ratio results were estimated separately for each of these two cohorts and then pooled using a
fixed-effect meta-analysis. Second, we used IVW to estimate the effect of own 25(OH)D or
calcium on own BW (with a total of 215,444 adult women and men reporting their own BW)
in UKB for comparison with the effect estimates of maternal 25(OH)D or calcium on off-
spring BW. Stronger effects of own (fetal) 25(OH)D/calcium on their BW (compared with
maternal gestational circulating levels of these on offspring BW) would suggest the possibil-
ity of our main MR analyses of maternal 25(OH)D/calcium levels on offspring BW being
biased by fetal effects (assuming that measurement error in offspring BW and own BW are
similar).
We performed three additional tests to investigate possible violations of MR assumptions:
MR-Egger [41] and weighted-median estimator [42], which were only used in UKB (which we
considered our main analysis cohort and which has adequate statistical power for these analy-
ses), and exploring SNP associations with confounders in UKB, ALSPAC, and EFSOCH (fur-
ther details of these approaches are provided in S5 Text).
Instrumental variable analysis applied to RCTs
Instrumental variable methods can be applied to RCTs to quantify the causal effect estimate
of the intermediate that the randomised treatment is assumed to influence [45]. For example,
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here we used RCTs of randomisation to vitamin D supplements to quantify the effect of cir-
culating 25(OH)D on BW. This differs from the original aim and analyses of these RCTs,
which was to determine the causal effect of the supplements. These analyses are similar to
MR, except here the instrumental variable is randomised status. This approach has the same
underlying assumptions as all instrumental variable analyses, including MR. However, we
assume that the key sources of violation of these assumptions will differ between the RCT
and MR analyses (e.g., in the RCTs, concealment of randomisation and intention-to-treat
analyses will be important, whereas in MR horizontal pleiotropy due to linkage disequilib-
rium will be important). Under this assumption, if results from our MR and RCT analyses
are consistent with each other, this increases the likelihood that this is the correct causal
effect [20].
We used data from recent systematic reviews and meta-analyses of supplements versus pla-
cebo in pregnant women for both 25(OH)D [16] and calcium [15] to identify individual RCTs
that could be used in our instrumental variable analyses applied to RCTs. As different RCTs
used different doses, type of supplement (e.g., vitamin D2 or D3), or mode of delivery (e.g.,
oral or injection), and because to date relatively little work has used instrumental variables in
RCTs to test causal effects, we a priori decided we would use a one-sample instrumental vari-
able approach and only include RCTs that provided both the difference in mean BW and dif-
ference in mean 25(OH)D/calcium by randomised arm. Each individual RCT in both reviews
was searched to identify those that provided difference in mean BW and 25(OH)D/calcium.
This resulted in us being able to include 24 (56%) out of 43 RCTs from the most recent preg-
nancy vitamin D supplementation systematic review (published 2017) and 6 (26%) out of 23
RCTs included in the most recent calcium supplementation systematic review (2015); all other
RCTs had either no information on differences in mean BW or differences in mean 25(OH)D/
calcium.
Two of the authors (WDT and DAL) independently extracted the weighted mean differ-
ences in 25(OH)D and BW by trial randomised arm (25[OH]D supplement or placebo/other
control), together with their respective CI values, from 24 RCTs that presented results for
both of these (N = 5,276 mother–offspring pairs) [16] (S3 Table). Similarly, for calcium, two
authors (WDT and M-CB) independently extracted mean differences and CIs for 6 RCTs (543
mother–offspring pairs) [15] (S4 Table). Standard errors were calculated by each of the inde-
pendent abstractors, and a third author (RMF) checked consistency between the abstractors
with any discrepancy resolved by discussion between four authors, WDT, DAL, M-CB, and
RMF. One of the calcium RCTs [46] provided a range of the mean difference, which we treated
as the 95% CIs when calculating the standard error.
We calculated the Wald ratio estimate for each RCT by dividing the difference in mean BW
by the difference in mean 25(OH)D (or calcium) and then pooled these using a fixed-effect
meta-analysis and tested for between-study heterogeneity using the I2 statistic and leave-one-
out analysis. For the vitamin D supplementation, RCTs’ differences in mean 25(OH)D were in
nmol/l, and for the calcium supplementation, RCTs’ differences in mean calcium were in mg/
dl. In order to make the instrumental variable analyses in RCT results comparable with our
two-sample MR results, for 25(OH)D we assumed that a 10% difference was equivalent to 6.2
nmol/l (the value for a 10% difference around the median of the distribution of pregnancy 25
[OH]D in ALSPAC), and we multiplied the Wald ratio estimates by 6.2 to scale the results so
that they represented the difference in mean BW per 10% increase in 25(OH)D. We did the
same with calcium but used 0.5 (0.5 mg/dl being the 1 SD difference value used in our MR
analysis) to scale results so that they represented the difference in mean BW per 1 SD of
calcium.
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Results
The characteristics of included participants from UKB, ALSPAC, and EFSOCH are shown in
Table 1. The SNP-outcome associations for UKB, ALSPAC, and EFSOCH are shown in S5, S6
and S7 Tables.
MR and instrumental variable analysis in RCTs do not support a clinically
important effect of 25(OH)D on BW
Our two-sample MR results provide no strong evidence of an effect of maternal circulating
25(OH)D on offspring BW, with consistent null findings in the main Wald ratio and IVW
analyses and also with the MR-Egger and weighted-median results using the UKB data (Fig 2).
There was no strong evidence for marked heterogeneity between the Wald ratio estimates for
each SNP (I2 = 0.0%), and results were consistent in leave-one-out analysis with the main
results (i.e., no SNPs removed) and with each other (S4 Fig). MR effects in ALSPAC and
EFSOCH were weakly positive but with wide CIs that included the null value (Fig 2). The effect
estimates were the same with and without adjustment for fetal genotype in ALSPAC and
EFSOCH, and there was no strong evidence that own 25(OH)D influenced own BW in UKB
(Fig 2). Our main MR effect estimate in UKB was −0.03 g (95% CI −2.48 to 2.42 g, p = 0.981)
per 10% increase in maternal circulating 25(OH)D. However, the RCT instrumental variable
effect was 5.94 g (95% CI 2.15–9.73, p = 0.002) per 10% increase in maternal circulating
25(OH)D (Fig 2). There was no strong evidence for marked heterogeneity between the instru-
mental variable in RCT estimates (I2 = 16.2%), and results were consistent with the main over-
all result and with each other in leave-one-out analysis (S5 Fig).
The difference between the MR and instrumental variable analyses in RCTs is small, and
the CIs for the two results overlap, suggesting that they are statistically consistent. To explore
this small difference further, we undertook post hoc risk-of-bias assessment of the 24 RCTs.
Fig 2. Causative effect estimates for maternal 25(OH)D on birth weight. ALSPAC, Avon Longitudinal Study of Parents and Children; EFSOCH,
Exeter Family Study of Childhood Health; MR, mendelian randomisation; RCT, randomised controlled trial.
https://doi.org/10.1371/journal.pmed.1002828.g002
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S8 Table summarises the results of this risk-of-bias assessment. Most studies were small, with
the numbers randomised being between 16 and 1,134 and only three of the 24 RCTs including
more than 200 participants. When it was reported (16 of the 24 trials), loss to follow-up ranged
from 1% to 31%. Only two of the RCTs (12% of participants) had definitely undertaken inten-
tion-to-treat analyses, and 12 (54% of studies) had used random sequence and concealed allo-
cation to treatment groups.
Though there were only a small number of genetic instruments, and thus limited ability to
test potential biases from horizontal pleiotropy and weak instruments, there was no strong evi-
dence that 25(OH)D synthesis or metabolism had an effect on BW (S6 Fig).
MR and instrumental variable analyses applied to RCTs give conflicting
results on the effect of calcium on BW
Our main two-sample MR results provide no strong evidence of an effect of maternal circulat-
ing calcium on offspring BW, with consistent null findings across the Wald ratio, IVW, and
weighted-median results using UKB. However, there was evidence of horizontal pleiotropy,
with the MR-Egger intercept being −2 g (95% CI −4 to −0.5 g, p = 0.025) and the effect estimate
suggesting a possible modest effect of 41 g (95% CI −18 to 100 g, p = 0.132) per 1 SD increase
in maternal circulating calcium, compared to the weak inverse effect in the IVW and Wald
ratio estimates of −20 g (95% CI −44 to 5 g, p = 0.116) (Fig 3). There was also evidence for het-
erogeneity between the Wald ratio estimates for each SNP (I2 = 62.4%), and removing one of
the SNPs (rs1801725) strengthened the inverse effect estimate to −61 g (95% CI −99 to −23 g,
p = 0.002) per 1 SD increase in maternal circulating calcium, with removal of the other six
SNPs resulting in estimates close to the main result and consistent with each other (S7 Fig).
The Wald ratio for only the rs1801725 SNP was 10 g (95% CI −22 to 41 g, p = 0.558) per 1 SD
increase in maternal circulating calcium. There was no evidence that fetal genotype influenced
Fig 3. Causative effect estimates for maternal calcium on birth weight. ALSPAC, Avon Longitudinal Study of Parents and Children; EFSOCH,
Exeter Family Study of Childhood Health; MR, mendelian randomisation; RCT, randomised controlled trial.
https://doi.org/10.1371/journal.pmed.1002828.g003
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the results, as results were similar with or without adjustment for it, and the IVW analyses for
adults’ own BW gave a similar result to the IVW analyses for first child’s BW (Fig 3). The RCT
instrumental variable effect on calcium suggested a strong positive effect that was inconsistent
with any of the MR estimates (including MR-Egger): 178 g (95% CI 121–236 g, p = 1.43 ×
10−9) change in BW per 1 SD increase in maternal circulating calcium (Fig 3). There was no
strong evidence for heterogeneity between the RCT instrumental variable results (I2 = 0.0%),
but the main result and leave-one-out analyses had wide CIs (S8 Fig). Given the marked differ-
ence in the instrumental variable results in RCTs compared with any of the MR analyses, we
(post hoc) looked for potential bias within the specific RCTs that we were able to include in
our one-sample instrumental variable analyses of calcium on BW. Of the six included RCTs,
three had fewer than 100 participants (Ns = 23 to 72), and the two largest RCTs (N = 120 and
274), together with two other studies, did not use intention-to-treat analysis (S9 Table), which
could result in biased effect estimates. The second-largest study (N = 120) was also judged by
the authors of the systematic review to have high risk of bias (or it was noted that there was
insufficient information to determine risk) across all of the specific domains they assessed (S9
Table).
Validity of the 25(OH)D and calcium genetic instruments
The magnitude of the 25(OH)D SNPs association with maternal circulating 25(OH)D in
ALSPAC was similar to the magnitudes reported in the source GWAS for five of the seven
SNPs. There were differences for rs8018720 (which was weakly inversely rather than positively
associated with 25[OH]D in ALSPAC) and for rs117913124 (a weaker positive difference in
ALSPAC when compared to source GWAS) (Table 3). Despite these differences, we found no
evidence of heterogeneity between the Wald ratios, and leave-one-out analyses found no evi-
dence of an outlier effect (see above).
Table 3. The 25(OH)D instruments’ effect on exposure in GWAS source and ALSPAC.
SNP Nearby
Genes
Effect
Allele
Effect Allele
Frequency
(GWAS
Reported)
GWAS No. of
Participants in
GWAS
Difference in Mean
25(OH)D per Allele From
GWAS, in natural log
(log) nmol/l (95% CI)
No. of
Participants in
ALSPAC
Difference in Mean
25(OH)D per Allele
From ALSPAC, in log
nmol/l (95% CI)
rs3755967 GC C 0.72 Jiang and
colleagues [19]
79,366 0.089 (0.084–0.094) 4,874 0.069 (0.048–0.091)
rs117913124 CYP2R1 G 0.975 Manousaki
and colleagues
[24]
42,274 0.21 (0.19–0.23)� 4,874 0.079 (0.018–0.139)
rs10741657 CYP2R1 A 0.4 Jiang and
colleagues [19]
79,366 0.031 (0.027–0.035) 4,874 0.01 (−0.010 to 0.029)
rs12785878 DHCR7 T 0.75 Jiang and
colleagues [19]
79,366 0.036 (0.032–0.04) 4,874 0.049 (0.026–0.071)
rs10745742 AMDHD1 T 0.41 Jiang and
colleagues [19]
79,366 0.017 (0.013–0.021) 4,874 0.029 (0.009–0.049)
rs8018720 SEC23A G 0.27 Jiang and
colleagues [19]
79,366 0.017 (0.012–0.022) 4,874 −0.037 (−0.062 to
−0.011)
rs17216707 CYP24A1 T 0.79 Jiang and
colleagues [19]
79,366 0.026 (0.021–0.031) 4,874 0.020 (−0.005 to 0.046)
�This result differs from that reported by Manousaki and colleagues. Their result was in units of SDs of 25(OH)D in log nmol/L. We converted that value to natural
logged nmol/l by estimating the value of an SD of log transformed nmol/L of 25(OH)D in the ALSPAC study.
Abbreviations: ALSPAC, Avon Longitudinal Study of Parents and Children; AMDHD1, Amidohydrolase Domain Containing 1; DHCR7, 7-Dehydrocholesterol
reductase; GWAS, genome-wide association studies; SNP, single-nucleotide polymorphism.
https://doi.org/10.1371/journal.pmed.1002828.t003
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Neither the 25(OH)D nor the calcium genetic instrumental variable–weighted allele scores
were associated with observed confounders in the UKB, ALSPAC, or EFSOCH, with the
exceptions of maternal height, education, and Townsend deprivation index (TDI). The score
for 25(OH)D was negatively associated with height in the UKB, positively associated with
height, and negatively associated with TDI in EFSOCH and showed no association in
ALSPAC; the score for calcium was negatively associated with educational level and positively
associated with TDI in UKB (S10 Table). Given these findings, and on advice from one of the
reviewers, we undertook further analyses, using multivariable MR [47], to explore whether
maternal height might have masked a positive effect of 25(OH)D on BW (maternal height
could be a masking confounder in these results, as it is inversely associated with 25[OH]D but
positively relates to BW) and whether maternal education confounded the MR effect estimate
of maternal calcium on BW (further details available in S5 Text). Results from the multivari-
able IVW MR analyses were consistent with those from the unadjusted IVW MR analyses, for
both the full adjustment of height for 25(OH)D–BW results and the partial maternal education
calcium–BW results (S11 Table).
Discussion
This study triangulated two approaches (two-sample MR and instrumental variables applied to
RCTs) assessing the effects of maternal circulating 25(OH)D and calcium on BW. Across the
main and all sensitivity MR analyses, we found no evidence that maternal 25(OH)D has an
important effect on BW, but applying instrumental variable analyses to RCTs, there was evi-
dence of a weak positive effect. Findings for maternal circulating calcium were inconsistent
across methods and sensitivity analyses, making it difficult for us to conclude from the data
used here what the effect of maternal circulating calcium on BW is.
Although the instrumental variable applied to RCT analyses for 25(OH)Ds effect suggested
a weak positive effect of 5.94 g (95% CI 2.15–9.73, p = 0.002) higher BW per 10% increase in
25(OH)D, this might be exaggerated by limitations of the original RCTs (S8 Table and recent
systematic review [16]) and is so small that it is unlikely to be of clinical or public health
importance. Our MR analyses are largely in European-origin populations, whereas the RCTs
were predominantly in South Asian or Middle Eastern populations, and several were also in
those with low 25(OH)D levels at the start of pregnancy. These population differences may
also have contributed to differences between the two approaches, though it is notable that the
RCTs suggest little evidence of an effect on BW even in these populations at high risk of vita-
min D insufficiency. One of the proposed mechanisms underlying the hypothesis that mater-
nal circulating 25(OH)D results in higher BW is by increasing offspring bone mineral density
(BMD). However, a recent large, well-conducted RCT found no evidence of an effect of mater-
nal vitamin D3 supplementation on offspring neonatal BMD (assessed within 2 weeks of birth)
[48]. When combined with our own findings, there is therefore little evidence to suggest that
maternal circulating 25(OH)D influences BW via increases in BMD. A recent MR study sug-
gested no evidence of circulating 25(OH)D affecting the risk of preeclampsia [49], which is
consistent with results of a meta-analysis of RCTs of vitamin D supplementation on pre-
eclampsia [16]. That same meta-analysis found no strong evidence that randomisation to vita-
min D supplementation influenced gestational diabetes risk, when restricting analyses to
RCTs with least risk of bias [16]. As preeclampsia and gestational diabetes affect BW [6], these
findings are consistent with our results suggesting maternal 25(OH)D does not affect BW.
It is possible that low circulating 25(OH)D levels are not a suitable indicator of vitamin D
deficiency, as 1,25(OH)2D is the biologically active form of vitamin D and remains within ref-
erence limits even when circulating 25(OH)D levels are low, suggesting valid genetic and RCT
Association of maternal circulating 25(OH)D and calcium on birth weight
PLOS Medicine | https://doi.org/10.1371/journal.pmed.1002828 June 18, 2019 15 / 24
instruments associated with 1,25(OH)2D levels could give different results. However, we are
not aware of such instruments, and circulating 25(OH)D has a longer half-life in the body,
making it a more stable measurement and possibly a better indicator of long-term vitamin D
exposure [50]. Furthermore, previous observational studies that underpin the hypothesis that
vitamin D levels are importantly related to BW, and a large number of other health outcomes,
have used 25(OH)D as the marker of exposure.
Although the main MR analyses did not support a causal effect of maternal calcium on off-
spring BW, sensitivity (MR-Egger and leave-one-out) analyses were not completely consistent
with the main MR effect estimates, and the instrumental variable analyses applied to RCTs
were markedly different from any of the MR results. There are a number of possible reasons
why we might have found these differences. The MR estimate may be biased by masking hori-
zontal pleiotropy, which both our MR-Egger and leave-one-out analyses suggest. Thus, the
MR-Egger effect estimate suggests a modest positive effect with wide CIs, and the leave-one-
out analyses suggest that the heterogeneity between individual SNP Wald ratios is driven by
one SNP, rs1801725, which when removed results in an inverse association (again suggesting
masking pleiotropy). rs1801725 is in the calcium-sensing receptor (CASR) gene, which codes
for the calcium-sensing receptor protein and is widely expressed in the parathyroid gland, kid-
neys, and intestines and regulated blood levels of calcium [51], whereas the other calcium
SNPs are near to loci that are not known to have such a direct effect on calcium levels and may
therefore be more prone to pleiotropy. The leave-one-out analyses, together with the Wald
ratio result for CASR rs1801725 alone and the MR-Egger result, all suggest that our main IVW
results might be biased by masking horizontal pleiotropy and that there is a modest positive
causal effect of calcium on BW. Possible sources of masking pleiotropy could be alterations to
glucose levels, as one of the genetic instruments (rs780094) is associated with fasting glucose,
which is known to influence BW [52]. However, although these sensitivity analyses suggest a
possible modest positive causal effect of maternal circulating calcium on BW, they have limited
statistical power, and therefore they are imprecisely estimated with wide CIs. Although we
were able to show most of the 25(OH)D SNPs related to pregnancy 25(OH)D, we were not
able to assess this for maternal gestational calcium. If the calcium SNPs have weaker associa-
tions with circulating calcium levels in pregnancy (than they do in the GWAS of men [25]),
this might bias towards the null any real effect of maternal pregnancy calcium on BW in our
analyses. During pregnancy, maternal circulating levels of calcium increase in order to support
healthy skeletal development. This is achieved through increasing absorption from the intes-
tines and through bone resorption in the mothers, but this process is, at least partially, under
the control of the fetus, which increases the secretion of parathyroid hormone-related protein
in response to low fetal plasma calcium [53]. Thus, fetal genetic variants might be important
genetic instruments for MR analyses of maternal circulating gestational calcium’s effect on
fetal skeletal development and hence BW.
With respect to the difference between MR and instrumental variable analyses in RCT
results, we might expect to see weaker effects from instrumental variable analyses in RCTs
than from MR analyses, as the former only tests differences in exposure from the time of ran-
domisation, whereas MR tests differences over most of life (and hence across all pregnancy tri-
mesters). On the other hand, for in utero exposures, timing rather than duration of exposure
might be important [20]. Though the fetus acquires all of its calcium from the mother through-
out pregnancy, some evidence suggests that 80% of calcium in a neonate’s bones is absorbed
during the third trimester (possibly because of an increase in maternal 1,25-dihydroxyvitamin
D levels in the third trimester) [54], which would mean that supplementation starting earlier
in pregnancy and continuing through to delivery might be necessary to ensure adequate levels
for bone development throughout the third trimester (and hence an effect on BW). Five of the
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six RCTs that we included in our analyses would fit with this, as supplementation began at or
before 23 weeks of gestation and continued until delivery (the one study that started supple-
mentation in the third trimester—28 to 31 weeks—only included 32 participants). Overall, we
might then expect the RCT and MR results to be similar. However, the results from the instru-
mental variable analyses in RCTs might be biased because of the inclusion of only six calcium
supplementation RCTs, with the two largest ones having important sources of bias (S9 Table).
Furthermore, whereas our MR analyses are largely in European-origin populations, the RCTs
were predominantly in non-European populations, in particular Latin American populations,
which may explain some of the differences.
Study strengths and limitations
To the best of our knowledge, this is the first study to compare results from MR and instru-
mental variable analyses applied to RCTs to investigate the effect of maternal circulating cal-
cium levels on offspring BW. The GWAS that we used for genetic instrument–exposure
associations (sample 1) in our two-sample MR did not provide the percentage variation in cal-
cium that all seven SNPs explained. However, based on a previous study that provided the R2
for one of these seven SNPs (rs1801725) [55], we know that our instrument with all seven
SNPs will explain at least 2% of the variation in circulating calcium. We have considerably
increased the sample size of our previous MR study of the effect of maternal circulating 25
(OH)D on offspring BW [6]. These additions have increased the strength of our instrument,
with the R2 in our study suggesting the genetic variants explained approximately 3% of varia-
tion in circulating 25(OH)D compared with<1% of the variation explained by the two SNPs
used in the previous MR study [6]. We have explored the validity of our genetic instrumental
variables using multiple sensitivity analyses and compared those results with instrumental var-
iable analyses applied to RCTs, in which summary results from the RCTs were extracted inde-
pendently by two people and checked for consistency with a third.
Key potential limitations include the low response to UKB and maternal report of first
child’s BW many years after their birth. Recent research suggests that a highly select cohort (as
in the case of UKB with a 5% response [56]) can result in selection bias in genetic or MR analy-
ses [57,58]. Self-report of BW and the rounding to 1 pound (about 0.454 kg) may have intro-
duced error in the BW measure in UKB, but this would be random with respect to genotype
and expected to bias results towards the null. The somewhat lower mean BW in UKB partici-
pants than in ALSPAC/EFSOCH is likely to reflect secular trends of increasing birth size over
time because of the fact that they reported the weight of first-born children only, whereas in
ALSPAC/EFSOCH index children are from any pregnancy. The ALSPAC/EFSOCH MR esti-
mates were stronger than the UKB estimates, though with very wide CIs reflecting their
smaller sample size, and there is no evidence that the results were statistically inconsistent with
those from UKB. These two cohorts were used in sensitivity analyses to explore whether the
main MR analyses might be biased by a path from maternal genotype via fetal genotype to
their BW. We have shown this is not the case. However, adjustment for fetal genotype could
introduce a spurious association between maternal and paternal genotype [44], and if fathers’
circulating 25(OH)D or calcium influenced offspring BW, this could bias our results. As it is
unlikely that fathers’ circulating levels of 25(OH)D or calcium could directly influence fetal
growth and offspring BW, we feel our offspring-adjusted results are unlikely to be biased. This
is also supported by the lack of any effect of own 25(OH)D or calcium on own BW in MR sen-
sitivity analyses in UKB.
In UKB, the 25(OH)D genetic risk score was negatively associated with height, and as it is
possible that greater maternal height results in greater BW, independently of the offspring
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genotype [59], this could mask any true positive effect of 25(OH)D on BW. We also found that
the calcium genetic instrument was associated with markers of socioeconomic position (area
deprivation and education), which could confound the MR estimated effect of calcium on BW.
However, results of multivariable MR adjusting the maternal 25(OH)D effect on BW for
maternal height and the maternal calcium effect on BW (partially) for maternal education
were consistent with the unadjusted results, suggesting that our results were not importantly
confounded.
Horizontal pleiotropy is a key source of bias for MR studies. For the effects of maternal
circulating 25(OH)D on BW, the consistency of results across all of our MR analyses suggests
that this has not been a key source of bias for that exposure. We did find evidence of potential
horizontal pleiotropy with maternal calcium effects and as discussed above and acknowledge
that further studies are required to explore that effect. We have assumed that genetic variants
that relate to 25(OH)D/calcium in (nonpregnant) women and men have the same magni-
tudes of association with these exposures in pregnant women. We were unable to test this for
calcium but did show that five out of the seven variants related similarly to circulating 25
(OH)D during pregnancy as in the GWAS. Removal of either of the two that did not associate
as strongly to 25(OH)D in pregnancy in our leave-one-out analyses was consistent with the
main results and all other leave-one-out analyses. Although we aimed to use randomisation
to use supplementation with vitamin D or calcium as an instrumental variable for RCTs,
some studies did not provide results from intention-to-treat analyses. Therefore, results from
these studies could be biased by noncompliance. The aim of triangulation is to compare
results from different methods that have different key sources of bias. Although both
approaches that we have used here rely on instrumental variables and have the same underly-
ing assumptions, the sources of violation of these assumptions differ between MR and instru-
mental variables applied to RCTs. For MR, horizontal pleiotropy is the key source of bias,
whereas for instrumental variables applied to RCT, it is lack of concealed random allocation
(which can introduce bias) and not using intention-to-treat analysis (which can produce a
path from the instrument to outcome and/or introduce confounding). The fact that there
was no marked difference between our MR and RCT analyses strengthens confidence in the
findings for 25(OH)D. However, as discussed above, the different results for calcium need
further exploration. In both our two-sample MR and instrumental variable analyses applied
to RCTs, we have used summary data and are unable to explore possible nonlinear effects,
though observational studies do not suggest that these are present. Similarly, we cannot
explore effect modification, but we are not aware of any evidence that the effects that we have
looked at do differ by other characteristics. Our MR analyses are in white European popula-
tions and may not generalise to other groups, such as those with different levels of skin
pigmentation and exposure to sunshine. However, most of the RCTs for vitamin D and cal-
cium supplementation are in non-Europeans. In particular, most vitamin D RCTs were in
Middle Eastern or South Asian populations, and a recent RCT in Bangladesh, which was not
included in the systematic review that we used in this paper for the RCT analyses, found that
vitamin D supplementation during pregnancy made no difference to BW [60]. Thus, even
in a low-income, dark-skinned population, maternal circulating 25(OH)D may not be an
important factor in BW.
In conclusion, our results suggest that maternal circulating 25(OH)D does not have a clini-
cally important effect on BW, so pregnancy supplementation with vitamin D is unlikely to
affect mean BW. Higher maternal circulating calcium may increase BW, but further research
is required to clarify this, including larger samples for undertaking pleiotropy ‘adjusted’ MR
analyses and larger, better-conducted RCTs of calcium supplementation.
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